Title : siRNA-Based Carrier-Free System for Synergistic Chemo/Chemodynamic/RNAi Therapy of Drug-Resistant Tumors.

Pub. Date : 2022 Jan 12

PMID : 34931793






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Herein, multidrug resistance protein 1 (MDR1) siRNA is used as the skeleton to assemble chemotherapeutic cisplatin (CDDP) and divalent copper ion (Cu2+) for constructing a carrier-free Cu-siMDR-CDDP system. Cisplatin ATP binding cassette subfamily B member 1 Homo sapiens
2 Herein, multidrug resistance protein 1 (MDR1) siRNA is used as the skeleton to assemble chemotherapeutic cisplatin (CDDP) and divalent copper ion (Cu2+) for constructing a carrier-free Cu-siMDR-CDDP system. Cisplatin ATP binding cassette subfamily B member 1 Homo sapiens
3 Herein, multidrug resistance protein 1 (MDR1) siRNA is used as the skeleton to assemble chemotherapeutic cisplatin (CDDP) and divalent copper ion (Cu2+) for constructing a carrier-free Cu-siMDR-CDDP system. Cisplatin ATP binding cassette subfamily B member 1 Homo sapiens
4 Herein, multidrug resistance protein 1 (MDR1) siRNA is used as the skeleton to assemble chemotherapeutic cisplatin (CDDP) and divalent copper ion (Cu2+) for constructing a carrier-free Cu-siMDR-CDDP system. Cisplatin ATP binding cassette subfamily B member 1 Homo sapiens
5 Besides, delivery of MDR1 siRNA is facilitated by HO -triggered lysosome destruction, thus inhibiting P-glycoprotein (P-gp) expression and CDDP efflux. Cisplatin ATP binding cassette subfamily B member 1 Homo sapiens